A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Schizophrenia
Interventions
DIETARY_SUPPLEMENT

Sarcosine

You will receive two grams of sarcosine or placebo per day. Each capsule will contain 500 mg of sarcosine or placebo. You will take two capsules twice per day, once in the morning and once in the evening, every day for six weeks. You can take the pills with or without food. You should continue to take all your other medications throughout the study.

Trial Locations (2)

02478

McLean Hospital, Brain Imaging Center, Belmont

02114

MGH Center for Addiction Medicine, Boston

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00538070 - A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia | Biotech Hunter | Biotech Hunter